Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
暂无分享,去创建一个
G. Ferretti | J. Dalphin | P. Carré | J. Faivre | V. Cottin | G. Prévot | B. Wallaert | M. Reynaud‐Gaubert | F. Lebargy | C. Danel | B. Crestani | F. Thivolet-Béjui | D. Valeyre | S. Marchand-Adam | R. Kessler | J. Cordier | B. Aguilaniu | J. Cadranel | B. Philippe | B. Stach | N. Just | D. Israel-Biet | P. Delaval | S. Kouzan | B. Bouquillon | D. Israel‐Biet | G. Prévôt
[1] F. Martinez,et al. [Pulmonary hypertension in chronic lung diseases]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[2] A. Russell,et al. Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models , 2014, European Respiratory Review.
[3] A. Bohadana,et al. Fundamentals of lung auscultation. , 2014, The New England journal of medicine.
[4] A. Abernethy,et al. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study , 2014, BMJ : British Medical Journal.
[5] V. Cottin,et al. Review of IPF diagnosis and management recommendations in Europe. , 2013, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[6] J. Dalphin,et al. [French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. From the National Reference and the Competence centers for rare diseases and the Société de Pneumologie de Langue Française]. , 2013, Revue des maladies respiratoires.
[7] J. Behr. Evidence-based treatment strategies in idiopathic pulmonary fibrosis , 2013, European Respiratory Review.
[8] K. Anstrom,et al. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. , 2013, Chest.
[9] Wei Xiao. [Combined pulmonary fibrosis and emphysema]. , 2013, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[10] J. Richard,et al. Fibrose pulmonaire: dans quels cas et sur quels critères envisager une admission en réanimation ? , 2013 .
[11] Demosthenes Bouros,et al. Combined pulmonary fibrosis and emphysema , 2013, Expert review of respiratory medicine.
[12] Charlie Strange,et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. , 2012, American journal of respiratory and critical care medicine.
[13] Luba Nalysnyk,et al. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature , 2012, European Respiratory Review.
[14] V. Cottin,et al. Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis? , 2012, European Respiratory Journal.
[15] A. Günther,et al. Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial , 2012, European Respiratory Journal.
[16] L. Spencer,et al. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? , 2012, European Respiratory Journal.
[17] K. Anstrom,et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.
[18] Kevin J Anstrom,et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.
[19] Joyce S Lee,et al. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.
[20] G. Raghu,et al. Efficacy And Safety Of Macitentan In Idiopathic Pulmonary Fibrosis: Results Of A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial , 2012, ATS 2012.
[21] F. Martinez,et al. ARTEMIS-IPF: A Placebo-Controlled Trial Of Ambrisentan In Idiopathic Pulmonary Fibrosis , 2012, ATS 2012.
[22] Joyce S Lee,et al. Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis , 2012, Thorax.
[23] C. Fell. Idiopathic pulmonary fibrosis: phenotypes and comorbidities. , 2012, Clinics in chest medicine.
[24] G. Raghu,et al. Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy? , 2012, European Respiratory Journal.
[25] G. Raghu. Idiopathic pulmonary fibrosis: increased survival with "gastroesophageal reflux therapy": fact or fallacy? , 2011, American journal of respiratory and critical care medicine.
[26] S. Sahn,et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. , 2011, American journal of respiratory and critical care medicine.
[27] H. Collard,et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[28] Moisés Selman,et al. Idiopathic pulmonary fibrosis , 2011, The Lancet.
[29] J. Egan,et al. Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis , 2011, European Respiratory Journal.
[30] M. Remy-Jardin,et al. Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses , 2011, European Respiratory Journal.
[31] A. Montgomery,et al. Ambulatory oxygen in interstitial lung disease , 2011, European Respiratory Journal.
[32] I. Noth,et al. Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis , 2011, European Respiratory Journal.
[33] S. Sahn,et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials , 2011, The Lancet.
[34] S. Sahn,et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. , 2011, American journal of respiratory and critical care medicine.
[35] H. Collard,et al. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[36] F. Martinez,et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema , 2010, European Respiratory Journal.
[37] N. Young. Telomere biology and telomere diseases: implications for practice and research. , 2010, Hematology. American Society of Hematology. Education Program.
[38] P. Brillet,et al. Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease , 2010, Thorax.
[39] H. Collard,et al. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. , 2010, The New England journal of medicine.
[40] Société française de cardiologie,et al. [Recommendations for clinical practice. Obstructive sleep apnea hypopnea syndrome in adults]. , 2010, Revue des maladies respiratoires.
[41] G. Raghu,et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.
[42] G. Raghu,et al. Pirfenidone in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.
[43] I. D. Johnston,et al. Cryptogenic fibrosing alveolitis and lung cancer: the BTS study , 2009, Thorax.
[44] H. Collard,et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. , 2009, Chest.
[45] M. Fujita,et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. , 2009, Respiratory medicine.
[46] M. Humbert,et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome , 2009, European Respiratory Journal.
[47] S. Sahn,et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial , 2009, The Lancet.
[48] T. Suarez,et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. , 2009, Chest.
[49] K. Chida,et al. Cumulative incidence of and predictive factors for lung cancer in IPF , 2009, Respirology.
[50] L. Cecchini,et al. Mechanical Ventilation in Patients with End-Stage Idiopathic Pulmonary Fibrosis , 2009, Respiration.
[51] J. Moran,et al. Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis. , 2009, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.
[52] N. Kohno,et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[53] G. Raghu,et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. , 2008, American journal of respiratory and critical care medicine.
[54] V. Cottin,et al. ANCA-associated lung fibrosis: analysis of 17 patients. , 2008, Respiratory medicine.
[55] G. Snell,et al. LUNG TRANSPLANTATION IN PULMONARY FIBROSIS: CHALLENGING EARLY OUTCOMES COUNTERBALANCED BY SURPRISINGLY GOOD OUTCOMES BEYOND 15 YEARS.: 1603 , 2008 .
[56] Y. Kondoh,et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis , 2008, Respirology.
[57] G. Paone,et al. Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens. , 2008, European review for medical and pharmacological sciences.
[58] A. Holland,et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease , 2008, Thorax.
[59] S. Nathan,et al. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant , 2007, European Respiratory Journal.
[60] W. Travis,et al. Early interstitial lung disease in familial pulmonary fibrosis. , 2007, American journal of respiratory and critical care medicine.
[61] A. Mehta,et al. Lung transplantation for idiopathic pulmonary fibrosis. , 2007, The Annals of thoracic surgery.
[62] M. Uder,et al. Progression of Fibrosis in Usual Interstitial Pneumonia: Serial Evaluation of the Native Lung after Single Lung Transplantation , 2007, Respiration.
[63] J. Bonnetblanc. Recommandations pour la pratique clinique , 2007 .
[64] R. Burgess,et al. Sleep-Related Breathing Disorders in Patients with Idiopathic Pulmonary Fibrosis , 2007, Lung.
[65] A. Nicholson,et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. , 2007, American journal of respiratory and critical care medicine.
[66] J. Golden,et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. , 2007, The Journal of thoracic and cardiovascular surgery.
[67] H. Collard,et al. Sildenafil improves walk distance in idiopathic pulmonary fibrosis. , 2007, Chest.
[68] V. Cottin. Interstitial lung disease: are we missing formes frustes of connective tissue disease? , 2006, European Respiratory Journal.
[69] A. Nicholson,et al. Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis , 2006, European Respiratory Journal.
[70] R. Hubbard,et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK , 2006, Thorax.
[71] B. Madden,et al. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease. , 2006, Vascular pharmacology.
[72] S. Nathan,et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. , 2006, Chest.
[73] A. Rubin,et al. Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids. , 2006, Respiratory medicine.
[74] D. Sugarbaker,et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. , 2006, The Journal of thoracic and cardiovascular surgery.
[75] A. Nicholson,et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features , 2006, European Respiratory Journal.
[76] G. Raghu,et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis , 2006, European Respiratory Journal.
[77] H Page McAdams,et al. Clinical and pathologic features of familial interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.
[78] P. Brillet,et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity , 2005, European Respiratory Journal.
[79] Katsutoshi Nakayama,et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. , 2005, Chest.
[80] T. Hartman,et al. Familial idiopathic pulmonary fibrosis: clinical features and outcome. , 2005, Chest.
[81] M. Vassallo,et al. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis , 2005, Palliative medicine.
[82] P. Pellikka,et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. , 2004, Chest.
[83] Douglas Curran-Everett,et al. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. , 2004, Chest.
[84] P. Grenier,et al. Pneumopathies interstitielles diffuses idiopathiques , 2004 .
[85] F. Al-Hameed,et al. Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. , 2004, Canadian respiratory journal.
[86] G. Raghu,et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. , 2004, The New England journal of medicine.
[87] R. Newton,et al. A study of the cough reflex in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[88] M. Molina-Molina,et al. Características clínicas y pronóstico de los pacientes con fibrosis pulmonar que ingresan en cuidados intensivos por insuficiencia respiratoria. Análisis de 20 casos , 2003 .
[89] M. Sutton,et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. , 2003, American journal of respiratory and critical care medicine.
[90] B. Afessa,et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. , 2002, American journal of respiratory and critical care medicine.
[91] M. Wahidi,et al. Progression of idiopathic pulmonary fibrosis in native lungs after single lung transplantation. , 2002, Chest.
[92] T. Laitinen,et al. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland , 2002, Thorax.
[93] Paul J. Friedman,et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.
[94] P. Jolliet,et al. Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis , 2001, Intensive Care Medicine.
[95] J. Tooze,et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.
[96] H. Mal,et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. , 2001, Chest.
[97] C. Guérin,et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. , 2001, Chest.
[98] R. Hubbard,et al. A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis , 2001, Thorax.
[99] D. Schroeder,et al. Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival. , 2000, American journal of respiratory and critical care medicine.
[100] G. Laurent,et al. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom , 2000, Thorax.
[101] M. Kitaichi,et al. Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[102] Stefano Nava,et al. Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis , 1999, Thorax.
[103] G. Raghu,et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[104] F. Martinez,et al. International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[105] S. Swensen,et al. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. , 1998, American journal of respiratory and critical care medicine.
[106] M A Schork,et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. , 1998, American journal of respiratory and critical care medicine.
[107] J. Hansen-Flaschen. Advanced lung disease. Palliation and terminal care. , 1997, Clinics in chest medicine.
[108] N. Müller,et al. Cryptogenic fibrosing alveolitis , 1997, The Lancet.
[109] R. G. Parrish,et al. Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. , 1996, American journal of respiratory and critical care medicine.
[110] D. Morrison,et al. Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. , 1992, Chest.
[111] G. Raghu,et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.
[112] M. Elliott,et al. Non-invasive mechanical ventilation for acute respiratory failure. , 1990, BMJ.
[113] I. D. Johnston,et al. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. , 1990, BMJ.
[114] J. Darbyshire,et al. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. , 1989, Thorax.
[115] B. Griffith,et al. Heart-lung transplantation. , 1987, Texas Heart Institute journal.
[116] R. Crystal,et al. Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. , 1986, The New England journal of medicine.
[117] M. Kamboh,et al. Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm). , 1986, Chest.
[118] Cotes Je,et al. LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA Report of the Medical Research Council Working Party , 1981, The Lancet.
[119] B. Burrows,et al. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.
[120] J. Allen,et al. Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. , 1978, The American journal of medicine.
[121] J SMITH,et al. Intensive care unit. , 1962, Nursing times.
[122] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[123] H. Olschewski,et al. [Pulmonary hypertension]. , 2012, Deutsche medizinische Wochenschrift.
[124] H. Collard,et al. Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis , 2012 .
[125] D. Lynch,et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[126] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[127] K. Kubo,et al. Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. , 2010, Internal medicine.
[128] G. Snell,et al. Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years. , 2008, Transplantation proceedings.
[129] G. Raghu,et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.
[130] M. Aydoğdu,et al. [Assessment of sleep with polysomnography in patients with interstitial lung disease]. , 2006, Tuberkuloz ve toraks.
[131] H. Date,et al. [Lung transplantation]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.
[132] Keith Rebello,et al. The Journal of Thoracic and Cardiovascular Surgery is the official publication of the American Association for Thoracic Surgery and the Western Thoracic Surgical Association. Copyright © 2003 American Association for Thoracic Surgery Downloaded from , 2002 .
[133] R. Hubbard,et al. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. , 2000, American journal of respiratory and critical care medicine.
[134] Keith McNeil,et al. International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). , 1998, American journal of respiratory and critical care medicine.
[135] G. Verleden,et al. The native lung after single lung transplantation: is it a problem? , 1996 .
[136] K. Sykes. Mechanical ventilation in acute respiratory failure. , 1994, European journal of anaesthesiology.
[137] Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. , 1980, Annals of internal medicine.
[138] L. Woolner,et al. Pulmonary fibrosis. , 1954, The Medical clinics of North America.